Medicare Enrolled

Dr. Lisa Strahm, M.D.

Endocrinology · San Diego, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1855 1ST AVE, San Diego, CA 92101
6194321033
In practice since 2014 (11 years)
NPI: 1952708075 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Strahm from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Strahm? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Strahm

Dr. Lisa Strahm is an endocrinology specialist in San Diego, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Strahm performed 623 Medicare services across 402 unique beneficiaries.

Between the years covered by Open Payments, Dr. Strahm received a total of $10,607 from 53 pharmaceutical and/or device companies across 469 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Strahm is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ 623 Medicare services $10,607 industry payments

Medicare Practice Summary

Medicare Utilization ↗
623
Medicare services
Bottom 47% in CA for endocrinology
402
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~57 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
299 $103 $235
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
151 $74 $163
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
59 $133 $353
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
38 $29 $77
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
29 $101 $262
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
22 $91 $233
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
13 $119 $285
Continuous glucose monitoring, tissue fluid
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin.
12 $56 $125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,607
Total received (2018-2024)
Avg $1,768/year across 6 years
Top 19% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
469
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,120 (95.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$488 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,733
2023
$2,187
2022
$2,358
2021
$1,771
2020
$464
2018
$94

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Senseonics, Incorporated
$400
Lilly USA, LLC
$345
Amgen Inc.
$314
Radius Health, Inc.
$273
Xeris Pharmaceuticals, Inc.
$211
Ascensia Diabetes Care Us Inc.
$192
Mannkind Corporation
$167
Novo Nordisk Inc
$150
Corcept Therapeutics
$135
Bayer Healthcare Pharmaceuticals Inc.
$134
SANOFI-AVENTIS U.S. LLC
$129
Verity Pharmaceuticals Inc.
$113
CeQur Corporation
$112
Astellas Pharma US Inc
$112
RECORDATI_RARE_DISEASES_INC.
$108
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
Dexcom, Inc.
$92
BETA BIONICS, INC.
$78
Tolmar, Inc.
$76
Tandem Diabetes Care, Inc.
$71
Abbott Laboratories
$68
Kyowa Kirin, Inc.
$64
Novartis Pharmaceuticals Corporation
$55
Esperion Therapeutics, Inc.
$41
Acella Pharmaceuticals, LLC
$35
Medtronic, Inc.
$25
PFIZER INC.
$22
ViiV Healthcare Company
$21
Boston Scientific Corporation
$19
Amphastar Pharmaceuticals, Inc.
$19
Antares Pharma, Inc.
$18
Neurocrine Biosciences, Inc.
$16
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 28.4% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,327
AstraZeneca Pharmaceuticals LP
$940
Corcept Therapeutics
$645
Horizon Therapeutics plc
$597
Ascensia Diabetes Care Us Inc.
$548
Radius Health, Inc.
$528
Amgen Inc.
$513
Novo Nordisk Inc
$438
SANOFI-AVENTIS U.S. LLC
$422
Insulet Corporation
$404
Senseonics, Incorporated
$400
Xeris Pharmaceuticals, Inc.
$372
Mannkind Corporation
$302
Abbott Laboratories
$267
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
Tandem Diabetes Care, Inc.
$203
Dexcom, Inc.
$203
CeQur Corporation
$185
Bayer Healthcare Pharmaceuticals Inc.
$178
MannKind Corporation
$154
RECORDATI_RARE_DISEASES_INC.
$128
Verity Pharmaceuticals Inc.
$113
Astellas Pharma US Inc
$112
Kyowa Kirin, Inc.
$109
Tolmar, Inc.
$107
Bayer HealthCare Pharmaceuticals Inc.
$106
ViiV Healthcare Company
$84
Antares Pharma, Inc.
$79
PFIZER INC.
$79
BETA BIONICS, INC.
$78
Nevro Corp.
$73
Novartis Pharmaceuticals Corporation
$73
Medtronic, Inc.
$70
Rhythm Pharmaceuticals, Inc.
$64
Amryt Pharma Holdings Ltd
$43
Esperion Therapeutics, Inc.
$41
Ultragenyx Pharmaceutical Inc.
$40
Acella Pharmaceuticals, LLC
$35
Supernus Pharmaceuticals, Inc.
$35
AbbVie Inc.
$30
Embecta Corp.
$29
GlaxoSmithKline, LLC.
$24
Merck Sharp & Dohme Corporation
$23
EMD Serono, Inc.
$22
Boston Scientific Corporation
$19
Amphastar Pharmaceuticals, Inc.
$19
Currax Pharmaceuticals LLC
$18
Neurocrine Biosciences, Inc.
$16
Amarin Pharma Inc.
$15
Zealand Pharma US, Inc.
$15
Clarus Therapeutics Inc.
$14
Merck Sharp & Dohme LLC
$14
Acerta Pharma LLC
$12
Top 3 companies account for 27.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano 2nd Gen Pen Needle · CABENUVA · CONTRAVE · CRYSVITA · CeQur Simplicity · Crysvita · DELSTRIGO · Dexcom G6 Transmitter · EMGALITY · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · EVERSENSE E3 SMART TRANSMITTER KIT · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LOKELMA · LYUMJEV · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · NEXLETOL · NOCDURNA · NP Thyroid 60 · OTREXUP · Omnia · Omnipod · Ozempic · Prolia · RECORLEV · RUKOBIA · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA 100/33 · SOMAVERT · SYNJARDY · Saxenda · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tlando · Tymlos · UBRELVY · Vascepa · Veozah · Wegovy · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in San Diego?
Compare endocrinologists in the San Diego area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
91
Per 100K population
2.8
County median income
$102,285
Nearest hospital
NMC San Diego
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Strahm is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Strahm experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Strahm performed 299 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Strahm receive payments from pharmaceutical companies?
Yes. Dr. Strahm received a total of $10,607 from 53 companies across 469 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Strahm's costs compare to other endocrinologists in San Diego?
Dr. Strahm's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Strahm) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →